Mineral Composition is Altered by Osteoblast Expression of an Engineered Gs-Coupled Receptor
- First Online:
- Cite this article as:
- Kazakia, G.J., Speer, D., Shanbhag, S. et al. Calcif Tissue Int (2011) 89: 10. doi:10.1007/s00223-011-9487-z
Activation of the Gs G protein–coupled receptor Rs1 in osteoblasts increases bone mineral density by 5- to 15-fold in mice and recapitulates histologic aspects of fibrous dysplasia of the bone. However, the effects of constitutive Gs signaling on bone tissue quality are not known. The goal of this study was to determine bone tissue quality in mice resulting from osteoblast-specific constitutive Gs activation, by the complementary techniques of FTIR spectroscopy and synchrotron radiation micro-computed tomography (SRμCT). Col1(2.3)-tTA/TetO-Rs1 double transgenic (DT) mice, which showed osteoblast-specific constitutive Gs signaling activity by the Rs1 receptor, were created. Femora and calvariae of DT and wild-type (WT) mice (6 and 15 weeks old) were analyzed by FTIR spectroscopy. WT and DT femora (3 and 9 weeks old) were imaged by SRμCT. Mineral-to-matrix ratio was 25% lower (P = 0.010), carbonate-to-phosphate ratio was 20% higher (P = 0.025), crystallinity was 4% lower (P = 0.004), and cross-link ratio was 11% lower (P = 0.025) in 6-week DT bone. Differences persisted in 15-week animals. Quantitative SRμCT analysis revealed substantial differences in mean values and heterogeneity of tissue mineral density (TMD). TMD values were 1,156 ± 100 and 711 ± 251 mg/cm3 (mean ± SD) in WT and DT femoral diaphyses, respectively, at 3 weeks. Similar differences were found in 9-week animals. These results demonstrate that continuous Gs activation in murine osteoblasts leads to deposition of immature bone tissue with reduced mineralization. Our findings suggest that bone tissue quality may be an important contributor to increased fracture risk in fibrous dysplasia patients.
KeywordsFourier transform infrared spectroscopySynchrotron micro-computed tomographyBone formationBone qualityMineralizationGs signalingRs1 transgenic miceReceptors activated solely by synthetic ligands (RASSLs)G protein–coupled receptorsFibrous dysplasia of bone
Osteoblast G protein–coupled receptors (GPCRs) are fundamental regulators of skeletal maintenance and repair. Activation of osteoblast Gs-GPCR signaling increases bone mass, as in pathological conditions such as fibrous dysplasia of the bone and McCune-Albright syndrome [1, 2]. However, the affected bone is associated with increased fragility. In contrast, intermittent activation of the parathyroid hormone receptor (PTH1R) by recombinant parathyroid hormone (teriparatide)  increases bone formation and is an important treatment for osteoporosis. Manipulation of skeletal GPCR signaling, therefore, is a potentially potent technique for regulating disease processes and enhancing repair of bone tissue .
The skeletal effects of Gs-GPCR signaling on bone formation were investigated with the Col1(2.3)-tTA/TetO-Rs1 mouse model of fibrous dysplasia of the bone. This model uses a synthetic biology approach  to activate the Gs signaling pathway in maturing mouse osteoblasts by the constitutive Gs activity of the Rs1 engineered receptor activated solely by a synthetic ligand (RASSL) [5, 6]. RASSLs are engineered receptors that no longer respond to endogenous hormones but are activated by synthetic small-molecule drugs. They have been useful for studying the roles of G-protein signaling in a variety of in vivo systems [7–10]. In the Col1(2.3)-tTA/TetO-Rs1 mouse model, Rs1 expression was sufficient to induce a dramatic increase in skeletal bone mass and trabecular bone formation . In addition, cortical bone was lost, the normal bone marrow canal was obliterated, and the normal bone marrow cellular components were replaced by a large number of small cells that histologically resemble young osteoblasts. These features show strong similarity to the bony lesions in patients with fibrous dysplasia of the bone, a disease that also results from activation of the Gs signaling pathway [1, 2].
While elevated osteoblast Gs signaling has significant effects on bone mass and structure, the quality of the resulting bone tissue has not been thoroughly investigated. Characteristics of bone tissue quality, including mineral content and composition, crystal size and perfection, and collagen matrix stability, are critical to the mechanical competence [11–14] and remodeling characteristics [15, 16] of bone. Therefore, evaluation of tissue quality metrics is crucial for understanding the anabolic effect of constitutive Gs signaling on bone and for developing effective treatments for skeletal pathology.
We applied two complementary strategies for assessing bone quality in mice with osteoblast-specific constitutive Gs signaling activity: Fourier transform infrared (FTIR) spectroscopy, to investigate tissue quality at the molecular level, and synchrotron radiation micro-computed tomography (SRμCT), to provide accurate quantification of bone tissue mineral density (TMD) at high spatial resolution.
FTIR spectroscopy provides a method for examining tissue quality and composition by measuring molecular bond vibration frequencies [17, 18]. FTIR spectra of calcified tissues typically provide information on the structure and environment of the carbonate and phosphate groups of the mineral phase and the amide groups of the organic matrix. Metrics of bone quality can be calculated from these data. Specifically, these parameters include mineral-to-matrix ratio (correlated to ash density [19, 20]), carbonate-to-phosphate ratio (reflecting the level of carbonate substitution into the apatite lattice [15, 21]), crystallinity (related to crystal size and perfection as determined by X-ray diffraction [22, 23]), and collagen cross-link ratio (the ratio of nonreducible to reducible cross-links, indicating collagen maturity and stability ). These FTIR parameters provide information on the structure and mineralization of the inorganic and organic components of bone.
SRμCT enables accurate TMD quantification at high spatial resolution. In this technique, a high photon flux monochromatic X-ray beam extracted from a synchrotron beam replaces the standard polychromatic X-ray beam used in conventional μCT devices. The use of a single X-ray beam energy eliminates beam-hardening artifacts, the high photon flux produces a high signal-to-noise ratio and high spatial resolution, and the use of a nearly parallel beam enables exact 3D tomographic reconstruction. Due to these factors, TMD quantification by SRμCT is more accurate than that by conventional μCT. SRμCT TMD assessment has been verified against gravimetric methods (ashing)  and 2D microradiography  and is currently considered the gold standard for high-resolution 3D TMD evaluation.
In this study, we used FTIR spectroscopy and SRμCT to evaluate measures of bone tissue mineralization, composition, and maturity in mice with osteoblast-specific constitutive Gs signaling activity. Our results show that the bone formed by activated Gs signaling is more immature and has lower mineralization than that of wild-type (WT) controls. These findings suggest that reduced bone quality contributes to increased bone fragility in fibrous dysplasia patients. In addition, our results illustrate that metrics of bone tissue quality are important in investigating signaling mechanisms.
Materials and Methods
All transgenic mouse studies were approved by and performed in accordance with the Institutional Animal Care and Use Committee and the Laboratory Animal Research Center at the University of California, San Francisco. ColI(2.3)-tTA/TetO-Rs1 double transgenic (DT) mice were generated by heterozygote crosses of mice carrying the TetO-Rs1 transgene  with mice carrying the ColI(2.3)-tTA transgene , as described . Transgene expression was activated by maintaining the mice on regular mouse chow without doxycycline (LabDiet 5053; PMI Nutrition, St. Louis, MO). These transgenic mice display osteoblast-specific constitutive Gs signaling activity through the Rs1 receptor. Previous qPCR assays on whole femora of 6-week-old adult mice showed that Rs1 expression was selectively and highly induced in the bones of DT mice . All studies compared DT mice to WT littermate controls.
Spectroscopy was performed on a benchtop interferometer system (Nexus 870, Thermo Electron). Spectra were acquired using 256 scans at a spectral resolution of 4 cm−1. A background scan was recorded immediately after each sample scan to facilitate background correction. After acquisition, the spectra were transferred to chemical imaging software (Isys; Spectral Dimensions, Olney, MD) for analysis. Spectra were baseline-adjusted and the integrated areas of the amide I (1,595–1,720 cm−1), ν1ν3 phosphate (PO43−, 895–1,215 cm−1), and v2 carbonate (CO32−, 840–890 cm−1) bands were calculated. Mineral-to-matrix (PO43−/amide I), carbonate-to-phosphate (CO32−/PO43−), and carbonate-to-matrix (CO32−/amide I) ratios were calculated from integrated areas of the respective peaks. Additionally, peak heights were measured at specific wave numbers: 1,020, 1,030, 1,660, and 1,690 cm−1. From these, a series of absorbance ratios were calculated to determine additional spectroscopic parameters. The ratio of 1,030 to 1,020 cm−1 represents the ratio of stoichiometric apatite to nonstoichiometric apatite, a measure of crystallinity. Finally, the ratio of 1,660 to 1,690 cm−1 represents the proportion of nonreducible to reducible cross-links in the collagen, indicative of collagen maturity.
Left femora from each of three 15-week-old WT mice were used to assess repeatability of FTIR measures. From each femur, a mid-diaphyseal section was isolated and processed into a homogeneous powder mixture of 1% bone by weight in KBr as described above. Three pellets were created from each batch of the homogenized mixture, and the remaining powder was stored in the desiccator to prevent hydration between each pellet preparation. Spectroscopy and analysis of the three pellets from each bone were performed consecutively on a single day, following the methods detailed in the previous section.
Synchrotron μCT Imaging
Whole-body DXA scans of WT and DT mice were performed for animals aged 3 weeks (n = 10 WT, 14 DT), 6 weeks (n = 10 WT, 10 DT), 9 weeks (n = 8 WT, 14 DT), and 15 weeks (n = 7 WT, 7 DT) to assess phenotype progression. Whole-body DXA scans were performed under anesthesia with 1% isoflurane in a Lunar PIXImus2 (GE Lunar, Waukesha, WI), as described previously .
Femora of 6-week-old DT and WT mice collected for histology were fixed in 10% neutral buffered formalin for 24 h. Undecalcified femora were embedded in polymethyl methacrylate , and 4-μ sections were cut on a hard-tissue microtome. Decalcified bones were processed in 10% EDTA, embedded in paraffin, sectioned, and stained with hematoxylin and eosin (H&E) by the Gladstone Institutes Histology Core (San Francisco, CA). Mid-diaphyseal regions of interest were visualized to grossly assess phenotypic changes.
Wilcoxon signed-rank tests revealed no significant differences in FTIR spectroscopic parameters between the two anatomic sites (femur, calvaria); therefore, values were averaged to produce a single result per animal. Results obtained from WT and DT mouse specimens were compared using t-tests or Wilcoxon rank sums tests as appropriate. Repeatability of FTIR measures was determined by calculating the coefficient of variation (CV) for each femoral specimen, then computing mean CV for the three femora used in the repeatability study.
FTIR spectroscopy was performed to assess bone quality in young (6 weeks) and mature (15 weeks) WT and DT mice. No differences in FTIR spectroscopic parameters were detected between the two anatomic sites we tested (femora and calvaria) for either WT or DT animals, despite the different bone-formation processes (endochondral vs. intramembranous) represented by the two sites.
FTIR analysis results for wild-type (WT) and double transgenic (DT) mice
WT (n = 6)
DT (n = 6)
WT (n = 6)
DT (n = 6)
5.14 ± 0.68
3.85 ± 0.66
5.77 ± 0.83
4.10 ± 0.60
0.059 ± 0.007*
0.053 ± 0.006
0.088 ± 0.03*
0.066 ± 0.011
0.012 ± 0.001*
0.014 ± 0.002
0.014 ± 0.001*
0.016 ± 0.001
1.06 ± 0.01
1.02 ± 0.01
1.05 ± 0.01
1.02 ± 0.01
Cross-link ratio 1,660/1,690
1.73 ± 0.08*
1.54 ± 0.15
1.59 ± 0.11*
1.41 ± 0.06
Repeatability of FTIR spectroscopic parameters
Cross-link ratio 1,660/1,690
Our results show that continuous Gs activation in mouse osteoblasts leads to deposition of large quantities of immature trabecular bone with reduced mineralization. FTIR spectroscopy revealed a 25–29% deficit in mineral-to-matrix ratio in the bones of mice expressing Rs1, and synchrotron imaging showed a reduced mean TMD. These findings are consistent with low levels of bone mineralization. Measures of mineral composition, mineral maturity, and collagen maturity also indicate significant abnormalities in bone formation induced by Gs activation in maturing osteoblasts. These alterations in tissue quality accompany dramatic structural changes, including greatly increased bone mass, increased heterogeneity of mineralization, disorganization of trabecular morphology, effacement of the cortical shell, and elimination of the medullary canal.
Our model is particularly relevant for GPCR diseases found in humans, including primary hyperparathyroidism and fibrous dysplasia of the bone such as that occurring in McCune-Albright syndrome. Patients with primary hyperparathyroidism present with marked cortical thinning and decreased cortical BMD [30, 31], possibly related to increased cortical porosity [32–34]. The elimination of the cortical compartment in DT mice is an extreme version of the cortical loss seen in primary hyperparathyroidism. However, the massive increase in trabecular volume observed in DT mice is not generally seen in patients with hyperparathyroidism. Bone from McCune-Albright syndrome patients shows a fibrous infiltrate, significant increases in trabecular bone formation, ablation of the marrow cavity, and an increased propensity to deformation and fracture . In addition, these patients accumulate unmineralized osteoid with a nonlamellar structure as well as mineralized tissue with markedly reduced mineral content [1, 36]. The mineralization abnormalities found in our mouse model of fibrous dysplasia may reflect those in patients with fibrous dysplasia of the bone.
FTIR spectroscopic measures provide bone tissue characterization at the molecular level and, importantly, are correlated with mechanical integrity and remodeling properties of the tissue. Mineral-to-matrix ratio increases as both primary and secondary mineralization progress and, therefore, is positively associated with tissue age [12, 37]. Studies of human tissue and animal models demonstrated positive correlations between mineral-to-matrix ratio and tissue stiffness and hardness [12, 38, 39]. Mineral-to-matrix ratio explains 50–60% of the variation in both tissue modulus and hardness [37, 40]. In our study, decreased mineral-to-matrix ratio in DT bone suggests the presence of immature bone with reduced resistance to deformation. Since FTIR crystallinity values are positively associated with tissue age, tissue yield strength, and stiffness [12, 14, 37], the decreased crystallinity we observed in DT bone substantiates the presence of immature tissue with reduced mechanical properties. We previously showed that DT animals have markedly elevated bone-turnover markers; display irregular, punctate bone formation by von Kossa staining and double fluorescent labeling; and have increased numbers of TRAP-positive osteoclasts . These characteristics support the conclusion that DT bone lesions contain regions with extremely high rates of bone formation and turnover, consistent with our findings of accumulated immature tissue.
Increased carbonate substitution has been associated with increased tissue age [12, 15, 41, 42], increased tissue indentation modulus and hardness , and—by a mechanism of reduced ductility—increased incidence of fracture  and inferior mechanical properties at the whole-bone level . Carbonate substitution in the hydroxyapatite lattice leads to a change in lattice dimensions and increased disorder of the crystalline structure . Further, mineral solubility is affected by carbonate content and increased carbonate content is thought to enhance bone resorption . Carbonate-to-phosphate ratio was significantly elevated in DT bone, indicating an alteration in crystal synthesis and perhaps playing a role in the high turnover observed in DT animals .
Collagen matrix biochemistry is also related to tissue age, mineralization, and mechanics. Intermolecular cross-linking provides the matrix tensile strength and influences whole-bone strength [46–49]. Cross-link formation also alters the rate of mineralization and microdamage accumulation , thereby providing a second mechanism for regulating the mechanical properties of bone . The ratio of mature to immature, reducible cross-links—quantified as cross-link ratio—increases with tissue maturity [52, 53] and correlates positively with indentation modulus . In DT bone, low cross-link ratio indicates immature tissue with reduced stiffness.
FTIR analyses showed that DT bone does not exhibit maturation between 6 and 15 weeks. In contrast, specimens from 6- and 15-week-old WT mice showed significant differences in carbonate-to-matrix and carbonate-to-phosphate ratios, indicative of increasingly mature tissue. Cross-link ratio decreased in WT animals, in contrast to the established association between cross-link ratio and matrix maturation.
SRμCT imaging was used to quantify mean TMD and distribution of TMD values, measures complementary to those determined through FTIR analysis. Consistent with the deficit in mineral-to-matrix ratio identified by FTIR, DT bone had mean TMD values 39% and 33% lower than WT bone at 3 and 9 weeks, respectively. SRμCT also revealed increased heterogeneity in mineral content in DT mice as reflected by the large standard deviation of TMD in DT bones at 3 and 9 weeks (151% and 88% higher, respectively). The alteration in distribution of mineralization values might significantly affect the overall material properties of DT bone; heterogeneous regions of tissue mineralization may hinder crack propagation and toughen tissue. It is intriguing to consider that the increased variation in TMD may represent a compensatory mechanism by which DT mice counteract the deficit in tissue mineralization. Increased tissue volume in DT animals may represent an additional adaptive response to the formation of hypomineralized tissue and loss of cortical structure. These changes may partially or fully compensate for any loss of whole-bone strength or stiffness. No spontaneous fractures have been identified in DT animals, perhaps supporting this hypothesis.
The presence of immature bone in our mouse model of fibrous dysplasia suggests that strategies for modulating bone formation, such as antiresorptive medications, may have therapeutic value for these patients. Since the fibrous dysplastic bone lesions appear to be reversible by inhibiting Gs signaling , the immature bone formation seen in our DT mice might also be reversed. This would be an important metric as potential therapies for fibrous dysplasia are developed.
Despite identifying significant effects of Rs1 signaling on bone mineralization, our study has several limitations. First, we were unable to perform direct measurement of mechanical competence in DT mice. Mechanical testing is challenging in DT specimens due to morphological abnormalities and heterogeneous mineralization. However, the compositional measures derived from FTIR and SRμCT data are highly associated with mechanical properties of bone tissue and give us insight into the mechanisms of increased fragility in fibrous dysplastic bone. Second, the ages of animals characterized by FTIR and SRμCT were different; this should be taken into consideration when making direct comparisons between analysis results. However, for each analysis technique, the younger animals (3 and 6 weeks old) were in the rapid skeletal growth phase, while the older animals (9 and 15 weeks old) had reached a plateau of bone accumulation. This is supported by BMD measurements and consistent with the observed sexual maturity window of 7–8 weeks in both WT and DT mice. Finally, our findings are based on samples from a relatively small number of animals. The significant abnormalities in tissue quality and skeletal structure we observed in our TD mice were surprisingly conserved between the two different anatomic sites sampled (femora and parietal bones of calvariae). This finding allowed us to compile results from the two skeletal sites and perform a conservative statistical analysis. Despite these limitations, we believe that our results provide new insight into the roles of Gs signaling in regulating the matrix formation process.
In conclusion, our results illustrate that activation of the Gs signaling pathway in maturing osteoblasts leads to a significant degradation of bone tissue quality in a mouse model of fibrous dysplasia. The striking influence of the fibrous dysplasia model on tissue quality metrics reinforces the paradigm that tissue quality, and not just quantity and structure, must be considered in the evaluation of any disease processes or potential therapies.
The authors thank Francoise Peyrin, PhD, the scientists of ESRF beamline ID19, and Andrew Burghardt for assistant with synchrotron imaging as well as Joyce Pang for assistance with specimen processing. This study was funded by NIH F32-AR053446 (to G. J. K.); NIH K08 AR056299-02 (to E. C. H.); the France-Berkeley Fund (to S. M.); NIH R01-HL60664 (to B. R. C.); the VA Merit Review Fund and NIH RO1-DK072071 (to R. A. N.). We also thank Mark Scott, Gary Howard, and the Gladstone Histology Core for valuable technical assistance and discussions. The J. David Gladstone Institutes received support from a National Center for Research Resources Grant (RR18928-01).